Request Demo
Last update 20 Mar 2025
EU-101
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms |
Target |
Action agonists |
Mechanism 4-1BB agonists(Tumor necrosis factor receptor superfamily member 9 agonists) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 319456222
Sequence Code 319456209VH
Sequence Code 319456199VL
Related
1
Clinical Trials associated with EU-101NCT04903873
An Open-Label, Phase 1/2 Study to Evaluate Safety, Efficacy, and Pharmacokinetics of EU101, an Agonistic Anti-CD137 (4-1BB) Monoclonal Antibody in Patients With Advanced Solid Tumors
100 Clinical Results associated with EU-101
Login to view more data
100 Translational Medicine associated with EU-101
Login to view more data
100 Patents (Medical) associated with EU-101
Login to view more data
100 Deals associated with EU-101
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | South Korea | 31 May 2021 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | United States | 31 May 2021 | |
| Metastatic Renal Cell Carcinoma | Phase 2 | South Korea | 31 May 2021 | |
| Metastatic Renal Cell Carcinoma | Phase 2 | United States | 31 May 2021 | |
| Prostatic Cancer | Phase 2 | South Korea | 31 May 2021 | |
| Prostatic Cancer | Phase 2 | United States | 31 May 2021 | |
| Colorectal Cancer | Discovery | South Korea | 31 May 2021 | |
| Non-Small Cell Lung Cancer | Discovery | United States | 28 May 2021 | |
| Neoplasms | Discovery | China | 01 Sep 2017 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free